Pharmacogenetic Screening: A Cost-Effective Str...

By Staff Writer

September 12, 2024

Introduction Major Depressive Disorder (MDD) is a significant public health issue, affecting around 3.8% of the global population. This translates to approximately 300 million people according to the

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.